|Bid||5.89 x 1400|
|Ask||6.29 x 1800|
|Day's Range||5.99 - 6.16|
|52 Week Range||2.75 - 7.49|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.88|
Subscribe to Yahoo Finance Plus to view Fair Value for VRAYLearn more
ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2021 financial results.
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
ViewRay, Inc. (NASDAQ: VRAY) today announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility. ViewRay will be exhibiting at the annual ASTRO 2021 conference in Chicago, IL from October 24― October 26 and will be highlighting the new technological advancements during the conference.